Compare Alcon AG (ALC) vs Invesco WilderHill Clean Energy ETF (PBW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Invesco WilderHill Clean Energy ETF — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Invesco WilderHill Clean Energy ETF trades at $35.16. The key difference: Alcon AG pays a 0.54% dividend while Invesco WilderHill Clean Energy ETF pays none, and Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, Alcon AG nearer its low. Which is the better fit depends on your goals.
| ALC | PBW | |
|---|---|---|
Market Cap | $32.69B | — |
Sector | Health | Sector/Thematic |
52-Week High | $92.22 | $46.99 |
52-Week Low | $62.02 | $21.70 |
Enterprise Value | $36.28B | — |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
PBW trades at $37.52, up 2.57% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF lacks key valuation metrics like P/E and P/S, and recent news highlights its volatility tied to interest rates and clean energy sector momentum. A dividend of $0.24 is scheduled for June 2026, but financial statements for the current period are unavailable.
The outlook is cautious due to bearish technicals and sensitivity to Treasury yields, though clean energy tailwinds from energy security concerns offer potential. Risks include rate cycle volatility and sector competition, with investor sentiment mixed amid Nasdaq pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Invesco WilderHill Clean Energy ETF
PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →
